These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1633910)

  • 1. Immunoneutralization of gonadotropin-releasing hormone and subsequent treatment with testosterone Silastic implants in rats: an approach toward developing a male contraceptive.
    Awoniyi CA; Kim WK; Hurst BS; Schlaff WD
    Fertil Steril; 1992 Aug; 58(2):403-8. PubMed ID: 1633910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative restoration of advanced spermatogenic cells in adult male rats made azoospermic by active immunization against luteinizing hormone or gonadotropin-releasing hormone.
    Awoniyi CA; Santulli R; Chandrashekar V; Schanbacher BD; Zirkin BR
    Endocrinology; 1989 Sep; 125(3):1303-9. PubMed ID: 2667955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of sexual function with testosterone in the gonadotropin-releasing hormone-immunized hypogonadotropic infertile male rat.
    Awoniyi CA; Reece MS; Hurst BS; Faber KA; Chandrashekar V; Schlaff WD
    Biol Reprod; 1993 Dec; 49(6):1170-6. PubMed ID: 8286600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone effects on spermatogenesis in the gonadotropin-releasing hormone-immunized rat.
    McLachlan RI; Wreford NG; Tsonis C; De Kretser DM; Robertson DM
    Biol Reprod; 1994 Feb; 50(2):271-80. PubMed ID: 8142546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenously administered testosterone maintains spermatogenesis quantitatively in adult rats actively immunized against gonadotropin-releasing hormone.
    Awoniyi CA; Zirkin BR; Chandrashekar V; Schlaff WD
    Endocrinology; 1992 Jun; 130(6):3283-8. PubMed ID: 1597140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoprolactinemia does not prevent restoration of normal spermatogenesis in gonadotropin-suppressed, testosterone-replaced rats.
    Awoniji CA; Roberts D; Chandrashekar V; Hurst BS; Tucker KE; Schlaff WD
    J Androl; 1996; 17(1):35-40. PubMed ID: 8833739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of growth hormone does not affect ongoing spermatogenesis in rats.
    Awoniyi CA; Veeramachaneni DN; Roberts D; Tucker KE; Chandrashekar V; Schlaff WD
    J Androl; 1999; 20(1):102-8. PubMed ID: 10100480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
    Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
    J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH immunization and male infertility: immunocontraception potential.
    Awoniyi CA
    Adv Contracept Deliv Syst; 1994; 10(3-4):279-90. PubMed ID: 12287842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Wallace AM; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of infertility in GnRH immunized male rats treated with subdermal implants of dihydrotestosterone (DHT).
    Awoniyi CA; Hurst BS; Reece MS; Kim WK; Schlaff WD
    Endocrine; 1996 Oct; 5(2):163-7. PubMed ID: 21153107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes suppresses fertility in vivo.
    Khan MA; Ferro VA; Koyama S; Kinugasa Y; Song M; Ogita K; Tsutsui T; Murata Y; Kimura T
    Vaccine; 2007 May; 25(18):3544-53. PubMed ID: 17316929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen does not affect the restoration of spermatogenesis in the gonadotrophin-releasing hormone-immunised adult rat.
    Meachem SJ; Robertson DM; Wreford NG; McLachlan RI; Stanton PG
    J Endocrinol; 2005 Jun; 185(3):529-38. PubMed ID: 15930179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of simultaneous gonadotropin-releasing hormone agonist and testosterone treatment on spermatogenesis and potential fertilizing capacity in male monkeys.
    Mann DR; Gould KG; Smith MM; Duffey T; Collins DC
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1215-24. PubMed ID: 3316265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of recombinant follicle-stimulating hormone on the restoration of spermatogenesis in the gonadotropin-releasing hormone-immunized adult rat.
    McLachlan RI; Wreford NG; de Kretser DM; Robertson DM
    Endocrinology; 1995 Sep; 136(9):4035-43. PubMed ID: 7649112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration.
    Pogach LM; Lee Y; Gould S; Giglio W; Huang HF
    Cancer Res; 1988 Aug; 48(15):4354-60. PubMed ID: 3134124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive.
    Bremner WJ; Bagatell CJ; Steiner RA
    J Clin Endocrinol Metab; 1991 Sep; 73(3):465-9. PubMed ID: 1874925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.